Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo

被引：18

作者：

Pandya, Amit G. ^{[1
,2
]}

Harris, John E. ^{[3
]}

Lebwohl, Mark ^{[4
]}

Hamzavi, Iltefat H. ^{[5
]}

Butler, Kathleen ^{[6
]}

Kuo, Fiona I. ^{[6
]}

Wei, Shaoceng ^{[6
]}

Rosmarin, David ^{[7
]}

机构：

[1] Sutter Hlth, Palo Alto Fdn Med Grp, Sunnyvale, CA 94086 USA

[2] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA

[3] UMass Med Sch, Dept Dermatol, Worcester, MA USA

[4] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY USA

[5] Henry Ford Med Ctr, Dept Dermatol & Skin Care, Detroit, MI USA

[6] Incyte, Wilmington, DC USA

[7] Tufts Med Ctr, Dept Dermatol, Boston, MA USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 12期

关键词：

D O I：

10.1016/j.jid.2022.05.1093

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：3352 / +

页数：8

共 9 条

[1] Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT [J].

Batchelor, Jonathan M. ;

Thomas, Kim S. ;

Akram, Perways ;

Azad, Jaskiran ;

Bewley, Anthony ;

Chalmers, Joanne R. ;

Cheung, Seau Tak ;

Duley, Lelia ;

Eleftheriadou, Viktoria ;

Ellis, Robert ;

Ferguson, Adam ;

Goulding, Jonathan M. R. ;

Haines, Rachel H. ;

Hamad, Hamdi ;

Ingram, John R. ;

Laguda, Bisola ;

Leighton, Paul ;

Levell, Nick ;

Makrygeorgou, Areti ;

Meakin, Garry D. ;

Millington, Adam ;

Ogboli, Malobi ;

Rajasekaran, Amirtha ;

Ravenscroft, Jane C. ;

Rogers, Andrew ;

Sach, Tracey H. ;

Santer, Miriam ;

Stainforth, Julia ;

Tan, Wei ;

Wahie, Shyamal ;

White, Jennifer ;

Whitton, Maxine E. ;

Williams, Hywel C. ;

Wright, Andrew ;

Montgomery, Alan A. .

HEALTH TECHNOLOGY ASSESSMENT, 2020, 24 (64) :1-+

[2] The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis [J].

Dong, Yujie ;

Yang, Qi ;

Guo, Baofeng ;

Zhu, Jiajing ;

Sun, Xiaojie .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (06) :461-471

[3] Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B [J].

Joshipura, Deep ;

Alomran, Abdulaziz ;

Zancanaro, Pedro ;

Rosmarin, David .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (06) :1205-+

[4] Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure [J].

Liu, Lucy Y. ;

Strassner, James P. ;

Refat, Maggi A. ;

Harris, John E. ;

King, Brett A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) :675-+

[5] Quality of life in people with vitiligo: a systematic review and meta-analysis [J].

Morrison, B. ;

Burden-Teh, E. ;

Batchelor, J. M. ;

Mead, E. ;

Grindlay, D. ;

Ratib, S. .

BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (06) :E338-E339

[6] Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms [J].

Quintas-Cardama, Alfonso ;

Vaddi, Kris ;

Liu, Phillip ;

Manshouri, Taghi ;

Li, Jun ;

Scherle, Peggy A. ;

Caulder, Eian ;

Wen, Xiaoming ;

Li, Yanlong ;

Waeltz, Paul ;

Rupar, Mark ;

Burn, Timothy ;

Lo, Yvonne ;

Kelley, Jennifer ;

Covington, Maryanne ;

Shepard, Stacey ;

Rodgers, James D. ;

Haley, Patrick ;

Kantarjian, Hagop ;

Fridman, Jordan S. ;

Verstovsek, Srdan .

BLOOD, 2010, 115 (15) :3109-3117

[7] Interfering with the IFN-gamma/CXCL10 pathway to develop new targeted treatments for vitiligo [J].

Rashighi, Mehdi ;

Harris, John E. .

ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (21)

[8]

Rosmarin D, 2020, LANCET, V396, P110, DOI 10.1016/S0140-6736(20)30609-7

[9] Vitiligo [J].

Taieb, Alain ;

Picardo, Mauro .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :160-U100

← 1 →